This website was launched by the European Medicines Agency in 2012 to provide public access to reports of suspected side effects (also known as suspected adverse drug reactions). These reports are submitted electronically to EudraVigilance by national medicines regulatory authorities and by pharmaceutical companies that hold marketing authorisations (licences) for the medicines.
EudraVigilance is a system designed for collecting reports of suspected side effects. These reports are used for evaluating the benefits and risks of medicines during their development and monitoring their safety following their authorisation in the European Economic Area (EEA). EudraVigilance has been in use since December 2001.
This website was launched to comply with the EudraVigilance Access Policy, which was developed to improve public health by supporting the monitoring of the safety of medicines and to increase transparency for stakeholders, including the general public.
The Management Board of the European Medicines Agency first approved the EudraVigilance Access Policy in December 2010. A revision was adopted by the Board in December 2015 based on the 2010 pharmacovigilance legislation. The policy aims to provide stakeholders such as national medicines regulatory authorities in the EEA, the European Commission, healthcare professionals, patients and consumers, as well as the pharmaceutical industry and research organisations, with access to reports on suspected side effects.
Transparency is a key guiding principle of the Agency, and is pivotal to building trust and confidence in the regulatory process. By increasing transparency, the Agency is better able to address the growing need among stakeholders, including the general public, for access to information. (Source.)
Their report through April 10, 2021 lists 6,662 deaths and 299,065 injuries following injections of four experimental COVID-19 shots:
A Health Impact News subscriber in Europe ran the reports for each of the four COVID-19 shots we are including here. This subscriber has volunteered to do this, and it is a lot of work to tabulate each reaction with injuries and fatalities, since there is no place on the EudraVigilance system we have found that tabulates all the results.
Here is the summary data through April 10, 2021.
Total reactions for the experimental mRNA vaccine Tozinameran (code BNT162b2, Comirnaty) from BioNTech/ Pfizer: 3,760 deaths and 134,606 injuries to 10/04/2021
10,021 Blood and lymphatic system disorders incl. 31 deaths
6,413 Cardiac disorders incl. 442 deaths
44 Congenital, familial and genetic disorders incl. 2 deaths
Ancient grey haired naked rebel and activist always looking to better the Human condition. Dreaming about what could be. Lifting the veil on the imposed illusion. Only a few will survive the depopulation wars fought by the (self proclaimed) 'Chosen Ones'. Only a few will survive the mindfuck. Maybe some of the stuff I write or share will be of some value (to you). I share it out of love knowing Mankind deserves so much better.
Editor, Webmaster, CEO, CFO, CIO, COO
Cairns, March 2018
MeWe profile text